WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 31, 2011: The Twelfth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (the Pharma Congress), www.PharmaCongress.com, November 2 - 4, 2011, will be held at the Mandarin Oriental in Washington, DC.

KEYNOTE SPEAKERS

Ariel Kaminer The Ethicist, New York Times Magazine, Former Editor, Arts & Leisure Section, New York Times, New York, NY John C. Lechleiter, PhD Chairman, President and Chief Executive Officer, Eli Lilly and Company, Chairman-elect, PhRMA Board of Directors, Indianapolis, IN Michael K. Loucks, Esq. Partner, Skadden Arps LLP, Former First Assistant US Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC Richard M. Mullane (Colonel, USAF, Ret.) Former NASA Astronaut, Recipient, Air Force Distinguished Flying Cross, Legion of Merit and the NASA Space Flight Medal, Albuquerque, NM Mary E. Riordan, Esq. Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC Vivian Robinson, Esq. Partner, McGuireWoods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK Shelley R. Slade, Esq. Whistleblower Attorney, Partner, Vogel, Slade & Goldstein, Former Senior Counsel, Health Care Fraud, Civil Division, US Department of Justice, Washington, DC Tony West, Esq. Head, Civil Division, US Department of Justice, Former California Special Assistant Attorney General, Former Assistant US Attorney, Northern California, Washington, DC Christopher D. Zalesky, JD, CCEP, RAC Vice President Global Policy and Guidance, Johnson & Johnson Health Care Compliance and Privacy, New Brunswick, NJ

GOVERNMENT FEATURED FACULTY

Thomas W. Abrams, RPh, MBA Director, Division of Drug Marketing, Advertising, and Communications, Center for Drug Evaluation and Research (CDER), Food and Drug Administration, Silver Spring, MD Michael Blume, Esq. Director, Office of Consumer Litigation, US Department of Justice, Washington, DC Joyce R. Branda, Esq. Director, Commercial Litigation Branch, US Department of Justice, Recipient, Presidential Meritorious Executive Award and Attorney General's Award for Exceptional Service, Washington, DC Nathaniel Edmonds, Esq. Assistant Chief, Foreign Corrupt Practices Act Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC Ann Meeker-O'Connell, MS Acting Associate Director of Risk Science, Intelligence and Prioritization, Office of Scientific Investigation (OSI), Center for Drug Evaluation and Research (CDER), Food and Drug Administration, Rockville, MD Jerry A. Menikoff, MD, JD Director, Office for Human Research Protections, Office of Public Health and Science, US Department of Health and Human Services, Former Director, Office of Human Subjects Research, National Institutes of Health, Rockville, MD Commander Krista Pedley, PharmD, MS Director, Office of Pharmacy Affairs (OPA), Health Resources and Services Administration (HRSA), Washington, DC

COMPLIANCE PROFESSIONALS AND IN HOUSE COUNSEL

Timothy Ayers, Esq. Associate General Counsel, Executive Director of Compliance, Seattle Genetics, Bothell, WA Hui Chen, Esq. Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer Inc., New York, NY Eve Costopoulos, Esq. Vice President, Chief Ethics & Compliance Officer, Eisai Inc., Woodcliff Lake, NJ Sujata T. Dayal, Esq. Corporate Vice President & Chief Compliance Officer, Biomet, Former Counsel, Domestic Legal Operations, Abbott Laboratories, Former Member, PCF Executive Committee, Warsaw, IN Maureen Doyle-Scharff, MBA, FACME Senior Director, Team Lead, Medical Education Group, Pfizer, Columbus, OH Gary F. Giampetruzzi, Esq. Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY Edmund Greenidge, Esq. Director, Grants and Charitable Contributions, Janssen Biotech, Inc., Philadelphia, PA Melanie Gross, JD, MPH Corporate Counsel, Genentech, Inc., South San Francisco, CA Elizabeth V. Jobes, Esq. Vice President and Chief Compliance Officer, Adolor, Philadelphia, PA Jeffrey S. Kasher, PhD Vice President Global Clinical Development, Eli Lilly and Company, Indianapolis, IN Andy Lee Senior Vice President, Head Global Clinical Operations, Genzyme, Boston, MA Daniel Moynihan, Esq. Chief Compliance Officer, EMD Serono, Rockland, MA Edward Nowicki, Esq. Deputy Compliance Officer- Global Programs, Senior Corporate Counsel, Corporate Compliance, Pfizer Inc., New York, NY Dieter Peise Associate Director Ethics & Compliance, Novartis, New York, NY Heather Reilly Powell, Esq. Director, Compliance Training and Reporting, Daiichi Sankyo, Inc., Former Associate Director, Global Compliance, Cephalon, Inc., Parsippany, NJ Arjun Rajaratnam, Esq. Chief Compliance Officer, Smith & Nephew, Former Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Member, PCF Executive Committee, Durham, NC Jeff Rosenbaum Global Head, Ethics & Compliance, Novartis Oncology, Florham Park, NJ Tom Schumacher, Esq. Vice President, Chief Ethics and Compliance Officer, Medtronic, Minneapolis, MN Hilary J. Schmidt, PhD Vice President Independent Grants and Learning, Sanofi-aventis US, Bridgewater, NJ Laura Sciarrino, Esq. Chief Legal Officer, Tercica, Inc., A Subsidiary of the Ipsen Group, Brisbane, CA Eric Siegel, JD, MBA Chief Compliance Officer, Incyte Corporation, Philadelphia, PA Joseph J. Skupen, CPA Senior Director, US Corporate Compliance, sanofi-aventis US, Bridgewater, NJ Caroline West, Esq. Senior Vice President, Chief Compliance and Risk Officer, Shire, Philadelphia, PA

ADVISORS AND LEGAL COUNSEL

Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY and Paris, France Dennis K. Barnes, JD, CPA Director, Healthcare Dispute, Compliance and Investigation Practice, Navigant Consulting, Inc., Philadelphia, PA Scott Bass, Esq. Partner and Co-Head, Global Life Sciences Practice, Sidley Austin LLP, Washington, DC John T. Bentivoglio, Esq. Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC Barry H. Boise, Esq. Partner, Pepper Hamilton LLP, Philadelphia, PA Emma Boyev Director Regulatory Compliance, Commercial Enterprise Office, Quintiles, Parsippany, NJ William E. Buzzeo, MS Vice President and General Manager, Compliance Solutions Division, Cegedim Relationship Management, Richmond, VA Colleen A. Conry, Esq. Partner and Co-Chair, Government Enforcement Practice Group, Ropes & Gray, Former Senior Litigation Counsel, Criminal Division, Fraud Section, US Department of Justice, Washington, DC Mark A. DeWyngaert, PhD Managing Director, Huron Consulting Group, LLC, New York, NY Jonathan L. Diesenhaus, Esq. Partner, Hogan Lovells US LLP, Former Senior Trial Counsel, Civil Division of the US Department of Justice, Washington, DC Jayson Dukes, CPA Senior Managing Director, FTI Consulting, New York, NY Susan Dunne Director, Life Sciences Practice, Huron Consulting Group, Washington, DC Fred Eaton, MBA Partner and Chair, Market Value Practice, Polaris Management Partners, New York, NY Sue Egan Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK Eileen Erdos Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP, Chicago, IL Thomas M. Gallagher, Esq. Partner and Chair, White Collar and Corporate Investigations Practice Group, Pepper Hamilton LLP, Former Prosecutor, Criminal Division, US Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA Virginia "Ginny" A. Gibson, Esq. Partner, Hogan Lovells US LLP, Former Executive Assistant US Attorney, Eastern District of Pennsylvania, Philadelphia, PA Thomas A. Gregory, CFA, MBA Principal, Ernst & Young LLP, Atlanta, GA Jeffrey L. Handwerker, Esq. Partner, Arnold & Porter, Washington, DC Stephen J. Immelt, Esq. Partner, Hogan Lovells, Former Assistant U.S. Attorney, District of Maryland, US Department of Justice, Baltimore, MD Mark A. Jensen, Esq. Partner, King & Spalding LLP, Washington, DC Paul E. Kalb, JD, MD Partner and Co-Head, Global Life Sciences Practice, Sidley Austin LLP, Washington, DC Jonathon L. Kellerman Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ Michael L. Koon, Esq. Partner, Shook Hardy, Washington, DC Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter, Washington, DC Daniel A. Kracov, Esq. Partner and Chair, FDA and Healthcare Practice, Arnold & Porter LLC, Washington, DC Mark Linver Managing Director, Life Sciences Practice, Huron Consulting Group, New York, NY Seth H. Lundy, Esq. Partner, King & Spalding LLP, Washington, DC Tracy Mastro, MBA Director, Huron Consulting Group, LLC, Washington, DC David E. Matyas, Esq. Partner, Epstein Becker & Green, Washington, DC Scott A. Memott, Esq. Partner, Morgan Lewis, Former Trial Attorney, Civil Division, US Department of Justice, Former Special Assistant US Attorney in Norfolk, Virginia, Washington, DC Kathleen Meriwether, Esq. Principal, Fraud Investigation & Dispute Services, Ernst & Young LLP, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA Marc Miller, CPA, CFF Partner, Forensic Practice, KPMG, New York, NY Timothy J. Nugent, CPA, CCEP Managing Director, KPMG LLP, Short Hills, NJ Suj Patel Director, Life Sciences Practice, Huron Consulting Group, New York, NY John Poulin Chief Solutions Architect, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, New York, NY Kelly N. "Nikki" Reeves, MPA, JD Partner, King & Spalding LLP, Washington, DC William A. Sarraille, Esq. Partner, Sidley Austin LLP, Washington, DC Paul J. Silver Practice Leader, Life Sciences Advisory Services, Huron Consulting Group, LLC, Atlanta, GA Peter S. Spivack, Esq. Partner, and Co-Leader, Investigations, White Collar and Fraud Practice Area, Hogan Lovells US LLP, Washington, DC Alexis Stroud, MBA, CQA Director, Quality and Compliance, QPharma, Inc., New York, NY Jack T. Tanselle Director, Healthcare Dispute, Compliance and Investigation Practice, Navigant Consulting, Inc., Chicago, IL Manny Tzavlakis Managing Director, Huron Consulting Group, LLC, New York, NY Constance A. Wilkinson, Esq. Member, Epstein Becker & Green, PC, Washington, DC Jerry Wolf Director, Healthcare Dispute, Compliance and Investigation Practice, Navigant Consulting, Inc., Philadelphia, PA David J. Wysocky Director, Pharmaceutical & Life Sciences Practice, PricewaterhouseCoopers LLP, Florham Park, NJ Richard L. Zimmerman Partner, Forensic Advisory Services, KPMG LLP, Los Angeles, CA

SAVE THE DATE
FIRST ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS AND BEST PRACTICES FORUM Sponsored by the Pharmaceutical Compliance Forum September 13 - 15, 2011 The Ritz-Carlton, Millenia Singapore www.AsianPharmaCongress.com	SIXTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS Sponsored by the Pharmaceutical Compliance Forum May 8 - 10, 2012 Budapest, Hungary www.InternationalPharmaCongress.com

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.